FMR LLC - Other* at Xilio Therapeutics, Inc.

Issuer-level insider activity

Role
Other*
Issuer symbol
XLO on Nasdaq
Identity 1 identity field
Entity type
Company
Source evidence 1 source field
SEC filing history
Open SEC filing history

No buys or sells have been reported by FMR LLC since 02 Jun 2025

Reported holdings for FMR LLC in Xilio Therapeutics, Inc.

Form 4 holding Other*

Xilio Therapeutics, Inc.

Security class
Common Stock
Shares / value
1,530,990
Estimated value
$1,270,722
Report date
26 Oct 2021
Price
$0.8300
Ownership
F-Prime Capital Partners Healthcare Fund IV LP
Form 4 holding Other*

Xilio Therapeutics, Inc.

Security class
Common Stock
Shares / value
372,215
Estimated value
$308,938
Report date
26 Oct 2021
Price
$0.8300
Ownership
Impresa Fund III Limited Partnership
Form 4 holding Other*

Xilio Therapeutics, Inc.

Security class
Common Stock
Shares / value
4,465
Estimated value
$3,706
Report date
26 Oct 2021
Price
$0.8300
Ownership
F-Prime Capital Partners Healthcare Advisors Fund IV LP
Form 4 holding Other*

Xilio Therapeutics, Inc.

Security class
Series A-1 Preferred Stock
Shares / value
0
Estimated value
Report date
26 Oct 2021
Price
Ownership
F-Prime Capital Partners Healthcare Fund IV LP
Underlying class
Common Stock
Underlying amount
Form 4 holding Other*

Xilio Therapeutics, Inc.

Security class
Series A Preferred Stock
Shares / value
0
Estimated value
Report date
26 Oct 2021
Price
Ownership
F-Prime Capital Partners Healthcare Fund IV LP
Underlying class
Common Stock
Underlying amount
Form 4 holding Other*

Xilio Therapeutics, Inc.

Security class
Series B Preferred Stock
Shares / value
0
Estimated value
Report date
26 Oct 2021
Price
Ownership
F-Prime Capital Partners Healthcare Advisors Fund IV LP
Underlying class
Common Stock
Underlying amount
Form 4 holding Other*

Xilio Therapeutics, Inc.

Security class
Series B Preferred Stock
Shares / value
0
Estimated value
Report date
26 Oct 2021
Price
Ownership
F-Prime Capital Partners Healthcare Fund IV LP
Underlying class
Common Stock
Underlying amount
Form 4 holding Other*

Xilio Therapeutics, Inc.

Security class
Series B Preferred Stock
Shares / value
0
Estimated value
Report date
26 Oct 2021
Price
Ownership
Impresa Fund III Limited Partnership
Underlying class
Common Stock
Underlying amount

Transaction history for FMR LLC in Xilio Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .